Human Phenotype Ontology 
Grandparent Node:
expand
Abnormality of the vasculature (HP:0002597)help
Grandparent Node:
expand
Neoplasm by anatomical site (HP:0011793)help
Parent Node:
expand
Vascular neoplasm (HP:0100742)help
..Starting node
..expand
Hemangioma (HP:0001028)help
Term ID: 1028
Name: Hemangioma
Synonym: Hemangiomata; Strawberry mark
Definition: A hemangioma is a benign tumor characterized by blood-filled spaces lined by benign endothelial cells. A hemangioma characterized by large endothelial spaces (caverns) is called a cavernous hemangioma (in contrast to a hemangioma with small endothelial spaces, which is called capillary hemangioma).
Comments:
Reference: HP:0001028
Genes and Diseases:
 
       Child Nodes:
........expandFacial hemangioma (HP:0000329) help
................... HP:0000996 Facial capillary hemangioma
................... HP:0004664 Facial midline hemangioma
................... HP:0007434 Plaque-like facial hemangioma
........expandCavernous hemangioma (HP:0001048) help
................... HP:0007486 Cavernous hemangioma of the face
........expandGlabellar hemangioma (HP:0001076) help
........expandCapillary hemangioma (HP:0005306) help
................... HP:0000996 Facial capillary hemangioma
................... HP:0005954 Pulmonary capillary hemangiomatosis
................... HP:0500090 Periocular capillary hemangioma
........expandHemangiomatosis (HP:0007461) help
................... HP:0005954 Pulmonary capillary hemangiomatosis
................... HP:0100761 Visceral angiomatosis
........expandChoroidal hemangioma (HP:0007872) help
........expandRetinal capillary hemangioma (HP:0009711) help
........expandCardiac hemangioma (HP:0011673) help
........expandArachnoid hemangiomatosis (HP:0012222) help
........expandTufted angioma (HP:0012329) help
........expandHepatic hemangioma (HP:0031207) help
........expandGlomeruloid hemangioma (HP:0031357) help
........expandPerineal hemangioma (HP:0031449) help

 Sister Nodes: 
..expandLymphatic vessel neoplasm (HP:0012797) help
InputHPO IDHPO termDistanceGeneGene id entrezDiseaseIdDiseaseNameDiseaseMIMConceptIDSourceTypical associationHGMD variantsClinVar variantsHGNC IDGeneMIM
 
HPO disease - gene - phenotype typical associations:
HP:0001028HP:0001028Hemangioma0AGGF1 CL E G H5510990308ORPHA1224684608464
HP:0001028HP:0001028Hemangioma0AKT1 CL E G H207176920Proteus syndrome176920C0085261OMIM112391164730
HP:0001028HP:0001028Hemangioma0ARID1B CL E G H57492135900Coffin-Siris syndrome 1135900C3281201OMIM118818040614556
HP:0001028HP:0001028Hemangioma0CPLX1 CL E G H108151941904p partial monosomy syndrome194190C1956097OMIM132309605032
HP:0001028HP:0001028Hemangioma0CTBP1 CL E G H14871941904p partial monosomy syndrome194190C1956097OMIM112494602618
HP:0001028HP:0001028Hemangioma0CTSA CL E G H5476256540Combined deficiency of sialidase AND beta galactosidase256540C0268233OMIM1399251613111
HP:0001028HP:0001028Hemangioma0CYP26C1 CL E G H340665398189ORPHA11120577608428
HP:0001028HP:0001028Hemangioma0DPM1 CL E G H8813608799Congenital disorder of glycosylation type 1E608799C1837396OMIM193005603503
HP:0001028HP:0001028Hemangioma0FGFRL1 CL E G H538341941904p partial monosomy syndrome194190C1956097OMIM173693605830
HP:0001028HP:0001028Hemangioma0FLT4 CL E G H2324153100Hereditary lymphedema type I153100C1704423OMIM1853767136352
HP:0001028HP:0001028Hemangioma0GPC6 CL E G H10082258315Omodysplasia 1258315C1850318OMIM194454604404
HP:0001028HP:0001028Hemangioma0HRAS CL E G H3265163200Epidermal nevus syndrome163200C0265318OMIM1345173190020
HP:0001028HP:0001028Hemangioma0KIF1B CL E G H23095171300Pheochromocytoma171300C0031511OMIM11316636605995
HP:0001028HP:0001028Hemangioma0KRAS CL E G H3845163200Epidermal nevus syndrome163200C0265318OMIM1456407190070
HP:0001028HP:0001028Hemangioma0LETM1 CL E G H39541941904p partial monosomy syndrome194190C1956097OMIM146556604407
HP:0001028HP:0001028Hemangioma0LETM1 CL E G H3954280Halal Setton Wang syndromeORPHA146556604407
HP:0001028HP:0001028Hemangioma0NELFA CL E G H7469280Halal Setton Wang syndromeORPHA1412768606026
HP:0001028HP:0001028Hemangioma0NRAS CL E G H4893163200Epidermal nevus syndrome163200C0265318OMIM1147989164790
HP:0001028HP:0001028Hemangioma0NSD2 CL E G H74681941904p partial monosomy syndrome194190C1956097OMIM11412766602952
HP:0001028HP:0001028Hemangioma0NSD2 CL E G H7468280Halal Setton Wang syndromeORPHA11412766602952
HP:0001028HP:0001028Hemangioma0PTEN CL E G H57282969ORPHA16589588601728
HP:0001028HP:0001028Hemangioma0RET CL E G H5979171300Pheochromocytoma171300C0031511OMIM14329967164761
HP:0001028HP:0001028Hemangioma0SDHB CL E G H6390171300Pheochromocytoma171300C0031511OMIM127910681185470
HP:0001028HP:0001028Hemangioma0SDHD CL E G H6392171300Pheochromocytoma171300C0031511OMIM117410683602690
HP:0001028HP:0001028Hemangioma0SEC23B CL E G H10483616858616858616858OMIM112610702610512
HP:0001028HP:0001028Hemangioma0TFAP2A CL E G H70201297ORPHA14411742107580
HP:0001028HP:0001028Hemangioma0VHL CL E G H7428263400Erythrocytosis, familial, 2263400C1837915OMIM161712687608537
HP:0001028HP:0001028Hemangioma0VHL CL E G H7428171300Pheochromocytoma171300C0031511OMIM161712687608537
HP:0001028HP:0001028Hemangioma0WHCR CL E G H74671941904p partial monosomy syndrome194190C1956097OMIM1127640
HP:0001028HP:0001028Hemangioma1AGGF1 CL E G H5510990308ORPHA1224684608464
HP:0001028HP:0001028Hemangioma1AKT1 CL E G H207176920Proteus syndrome176920C0085261OMIM112391164730
HP:0001028HP:0001028Hemangioma1ARID1B CL E G H57492135900Coffin-Siris syndrome 1135900C3281201OMIM118818040614556
HP:0001028HP:0001028Hemangioma1CPLX1 CL E G H108151941904p partial monosomy syndrome194190C1956097OMIM132309605032
HP:0001028HP:0001028Hemangioma1CTBP1 CL E G H14871941904p partial monosomy syndrome194190C1956097OMIM112494602618
HP:0001028HP:0001028Hemangioma1CTSA CL E G H5476256540Combined deficiency of sialidase AND beta galactosidase256540C0268233OMIM1399251613111
HP:0001028HP:0001028Hemangioma1CYP26C1 CL E G H340665398189ORPHA11120577608428
HP:0001028HP:0001028Hemangioma1DPM1 CL E G H8813608799Congenital disorder of glycosylation type 1E608799C1837396OMIM193005603503
HP:0001028HP:0001028Hemangioma1FGFRL1 CL E G H538341941904p partial monosomy syndrome194190C1956097OMIM173693605830
HP:0001028HP:0001028Hemangioma1FLT4 CL E G H2324153100Hereditary lymphedema type I153100C1704423OMIM1853767136352
HP:0001028HP:0001028Hemangioma1GPC6 CL E G H10082258315Omodysplasia 1258315C1850318OMIM194454604404
HP:0001028HP:0001028Hemangioma1HRAS CL E G H3265163200Epidermal nevus syndrome163200C0265318OMIM1345173190020
HP:0001028HP:0001028Hemangioma1KIF1B CL E G H23095171300Pheochromocytoma171300C0031511OMIM11316636605995
HP:0001028HP:0001028Hemangioma1KRAS CL E G H3845163200Epidermal nevus syndrome163200C0265318OMIM1456407190070
HP:0001028HP:0001028Hemangioma1LETM1 CL E G H39541941904p partial monosomy syndrome194190C1956097OMIM146556604407
HP:0001028HP:0001028Hemangioma1LETM1 CL E G H3954280Halal Setton Wang syndromeORPHA146556604407
HP:0001028HP:0001028Hemangioma1NELFA CL E G H7469280Halal Setton Wang syndromeORPHA1412768606026
HP:0001028HP:0001028Hemangioma1NRAS CL E G H4893163200Epidermal nevus syndrome163200C0265318OMIM1147989164790
HP:0001028HP:0001028Hemangioma1NSD2 CL E G H74681941904p partial monosomy syndrome194190C1956097OMIM11412766602952
HP:0001028HP:0001028Hemangioma1NSD2 CL E G H7468280Halal Setton Wang syndromeORPHA11412766602952
HP:0001028HP:0001028Hemangioma1PTEN CL E G H57282969ORPHA16589588601728
HP:0001028HP:0001028Hemangioma1RET CL E G H5979171300Pheochromocytoma171300C0031511OMIM14329967164761
HP:0001028HP:0001028Hemangioma1SDHB CL E G H6390171300Pheochromocytoma171300C0031511OMIM127910681185470
HP:0001028HP:0001028Hemangioma1SDHD CL E G H6392171300Pheochromocytoma171300C0031511OMIM117410683602690
HP:0001028HP:0001028Hemangioma1SEC23B CL E G H10483616858616858616858OMIM112610702610512
HP:0001028HP:0001028Hemangioma1TFAP2A CL E G H70201297ORPHA14411742107580
HP:0001028HP:0001028Hemangioma1VHL CL E G H7428263400Erythrocytosis, familial, 2263400C1837915OMIM161712687608537
HP:0001028HP:0001028Hemangioma1VHL CL E G H7428171300Pheochromocytoma171300C0031511OMIM161712687608537
HP:0001028HP:0001028Hemangioma1WHCR CL E G H74671941904p partial monosomy syndrome194190C1956097OMIM1127640
HP:0001028HP:0001028Hemangioma2AGGF1 CL E G H5510990308ORPHA1224684608464
HP:0001028HP:0001028Hemangioma2AKT1 CL E G H207176920Proteus syndrome176920C0085261OMIM112391164730
HP:0001028HP:0001028Hemangioma2ARID1B CL E G H57492135900Coffin-Siris syndrome 1135900C3281201OMIM118818040614556
HP:0001028HP:0001028Hemangioma2CPLX1 CL E G H108151941904p partial monosomy syndrome194190C1956097OMIM132309605032
HP:0001028HP:0001028Hemangioma2CTBP1 CL E G H14871941904p partial monosomy syndrome194190C1956097OMIM112494602618
HP:0001028HP:0001028Hemangioma2CTSA CL E G H5476256540Combined deficiency of sialidase AND beta galactosidase256540C0268233OMIM1399251613111
HP:0001028HP:0001028Hemangioma2CYP26C1 CL E G H340665398189ORPHA11120577608428
HP:0001028HP:0001028Hemangioma2DPM1 CL E G H8813608799Congenital disorder of glycosylation type 1E608799C1837396OMIM193005603503
HP:0001028HP:0001028Hemangioma2FGFRL1 CL E G H538341941904p partial monosomy syndrome194190C1956097OMIM173693605830
HP:0001028HP:0001028Hemangioma2FLT4 CL E G H2324153100Hereditary lymphedema type I153100C1704423OMIM1853767136352
HP:0001028HP:0001028Hemangioma2GPC6 CL E G H10082258315Omodysplasia 1258315C1850318OMIM194454604404
HP:0001028HP:0001028Hemangioma2HRAS CL E G H3265163200Epidermal nevus syndrome163200C0265318OMIM1345173190020
HP:0001028HP:0001028Hemangioma2KIF1B CL E G H23095171300Pheochromocytoma171300C0031511OMIM11316636605995
HP:0001028HP:0001028Hemangioma2KRAS CL E G H3845163200Epidermal nevus syndrome163200C0265318OMIM1456407190070
HP:0001028HP:0001028Hemangioma2LETM1 CL E G H39541941904p partial monosomy syndrome194190C1956097OMIM146556604407
HP:0001028HP:0001028Hemangioma2LETM1 CL E G H3954280Halal Setton Wang syndromeORPHA146556604407
HP:0001028HP:0001028Hemangioma2NELFA CL E G H7469280Halal Setton Wang syndromeORPHA1412768606026
HP:0001028HP:0001028Hemangioma2NRAS CL E G H4893163200Epidermal nevus syndrome163200C0265318OMIM1147989164790
HP:0001028HP:0001028Hemangioma2NSD2 CL E G H74681941904p partial monosomy syndrome194190C1956097OMIM11412766602952
HP:0001028HP:0001028Hemangioma2NSD2 CL E G H7468280Halal Setton Wang syndromeORPHA11412766602952
HP:0001028HP:0001028Hemangioma2PTEN CL E G H57282969ORPHA16589588601728
HP:0001028HP:0001028Hemangioma2RET CL E G H5979171300Pheochromocytoma171300C0031511OMIM14329967164761
HP:0001028HP:0001028Hemangioma2SDHB CL E G H6390171300Pheochromocytoma171300C0031511OMIM127910681185470
HP:0001028HP:0001028Hemangioma2SDHD CL E G H6392171300Pheochromocytoma171300C0031511OMIM117410683602690
HP:0001028HP:0001028Hemangioma2SEC23B CL E G H10483616858616858616858OMIM112610702610512
HP:0001028HP:0001028Hemangioma2TFAP2A CL E G H70201297ORPHA14411742107580
HP:0001028HP:0001028Hemangioma2VHL CL E G H7428263400Erythrocytosis, familial, 2263400C1837915OMIM161712687608537
HP:0001028HP:0001028Hemangioma2VHL CL E G H7428171300Pheochromocytoma171300C0031511OMIM161712687608537
HP:0001028HP:0001028Hemangioma2WHCR CL E G H74671941904p partial monosomy syndrome194190C1956097OMIM1127640
HP:0001028HP:0001028Hemangioma3AGGF1 CL E G H5510990308ORPHA1224684608464
HP:0001028HP:0001028Hemangioma3AKT1 CL E G H207176920Proteus syndrome176920C0085261OMIM112391164730
HP:0001028HP:0001028Hemangioma3ARID1B CL E G H57492135900Coffin-Siris syndrome 1135900C3281201OMIM118818040614556
HP:0001028HP:0001028Hemangioma3CPLX1 CL E G H108151941904p partial monosomy syndrome194190C1956097OMIM132309605032
HP:0001028HP:0001028Hemangioma3CTBP1 CL E G H14871941904p partial monosomy syndrome194190C1956097OMIM112494602618
HP:0001028HP:0001028Hemangioma3CTSA CL E G H5476256540Combined deficiency of sialidase AND beta galactosidase256540C0268233OMIM1399251613111
HP:0001028HP:0001028Hemangioma3CYP26C1 CL E G H340665398189ORPHA11120577608428
HP:0001028HP:0001028Hemangioma3DPM1 CL E G H8813608799Congenital disorder of glycosylation type 1E608799C1837396OMIM193005603503
HP:0001028HP:0001028Hemangioma3FGFRL1 CL E G H538341941904p partial monosomy syndrome194190C1956097OMIM173693605830
HP:0001028HP:0001028Hemangioma3FLT4 CL E G H2324153100Hereditary lymphedema type I153100C1704423OMIM1853767136352
HP:0001028HP:0001028Hemangioma3GPC6 CL E G H10082258315Omodysplasia 1258315C1850318OMIM194454604404
HP:0001028HP:0001028Hemangioma3HRAS CL E G H3265163200Epidermal nevus syndrome163200C0265318OMIM1345173190020
HP:0001028HP:0001028Hemangioma3KIF1B CL E G H23095171300Pheochromocytoma171300C0031511OMIM11316636605995
HP:0001028HP:0001028Hemangioma3KRAS CL E G H3845163200Epidermal nevus syndrome163200C0265318OMIM1456407190070
HP:0001028HP:0001028Hemangioma3LETM1 CL E G H39541941904p partial monosomy syndrome194190C1956097OMIM146556604407
HP:0001028HP:0001028Hemangioma3LETM1 CL E G H3954280Halal Setton Wang syndromeORPHA146556604407
HP:0001028HP:0001028Hemangioma3NELFA CL E G H7469280Halal Setton Wang syndromeORPHA1412768606026
HP:0001028HP:0001028Hemangioma3NRAS CL E G H4893163200Epidermal nevus syndrome163200C0265318OMIM1147989164790
HP:0001028HP:0001028Hemangioma3NSD2 CL E G H74681941904p partial monosomy syndrome194190C1956097OMIM11412766602952
HP:0001028HP:0001028Hemangioma3NSD2 CL E G H7468280Halal Setton Wang syndromeORPHA11412766602952
HP:0001028HP:0001028Hemangioma3PTEN CL E G H57282969ORPHA16589588601728
HP:0001028HP:0001028Hemangioma3RET CL E G H5979171300Pheochromocytoma171300C0031511OMIM14329967164761
HP:0001028HP:0001028Hemangioma3SDHB CL E G H6390171300Pheochromocytoma171300C0031511OMIM127910681185470
HP:0001028HP:0001028Hemangioma3SDHD CL E G H6392171300Pheochromocytoma171300C0031511OMIM117410683602690
HP:0001028HP:0001028Hemangioma3SEC23B CL E G H10483616858616858616858OMIM112610702610512
HP:0001028HP:0001028Hemangioma3TFAP2A CL E G H70201297ORPHA14411742107580
HP:0001028HP:0001028Hemangioma3VHL CL E G H7428263400Erythrocytosis, familial, 2263400C1837915OMIM161712687608537
HP:0001028HP:0001028Hemangioma3VHL CL E G H7428171300Pheochromocytoma171300C0031511OMIM161712687608537
HP:0001028HP:0001028Hemangioma3WHCR CL E G H74671941904p partial monosomy syndrome194190C1956097OMIM1127640
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0001028HP:0001028Hemangioma0ANTXR1 CL E G H841682067ORPHA01421014606410
HP:0001028HP:0001028Hemangioma0CDON CL E G H50937280200ORPHA01317104608707
HP:0001028HP:0001028Hemangioma0DISP1 CL E G H84976280200ORPHA01119711607502
HP:0001028HP:0001028Hemangioma0DLL1 CL E G H28514280200ORPHA0192908606582
HP:0001028HP:0001028Hemangioma0FGF8 CL E G H2253280200ORPHA0413686600483
HP:0001028HP:0001028Hemangioma0FGFR1 CL E G H2260280200ORPHA02653688136350
HP:0001028HP:0001028Hemangioma0FOXH1 CL E G H8928280200ORPHA0333814603621
HP:0001028HP:0001028Hemangioma0GAS1 CL E G H2619280200ORPHA064165139185
HP:0001028HP:0001028Hemangioma0GLI2 CL E G H2736280200ORPHA0884318165230
HP:0001028HP:0001028Hemangioma0LEMD3 CL E G H235921306Choreoacanthocytosis amyotrophicORPHA03428887607844
HP:0001028HP:0001028Hemangioma0NODAL CL E G H4838280200ORPHA0257865601265
HP:0001028HP:0001028Hemangioma0PTCH1 CL E G H5727280200ORPHA05299585601309
HP:0001028HP:0001028Hemangioma0SHH CL E G H6469280200ORPHA022110848600725
HP:0001028HP:0001028Hemangioma0SIX3 CL E G H6496280200ORPHA09110889603714
HP:0001028HP:0001028Hemangioma0SUFU CL E G H51684280200ORPHA04716466607035
HP:0001028HP:0001028Hemangioma0TDGF1 CL E G H6997280200ORPHA0611701187395
HP:0001028HP:0001028Hemangioma0TGIF1 CL E G H7050280200ORPHA02811776602630
HP:0001028HP:0001028Hemangioma0ZIC2 CL E G H7546280200ORPHA012312873603073
HP:0001028HP:0001028Hemangioma1ANTXR1 CL E G H841682067ORPHA01421014606410
HP:0001028HP:0001028Hemangioma1CDON CL E G H50937280200ORPHA01317104608707
HP:0001028HP:0001028Hemangioma1DISP1 CL E G H84976280200ORPHA01119711607502
HP:0001028HP:0001028Hemangioma1DLL1 CL E G H28514280200ORPHA0192908606582
HP:0001028HP:0001028Hemangioma1FGF8 CL E G H2253280200ORPHA0413686600483
HP:0001028HP:0001028Hemangioma1FGFR1 CL E G H2260280200ORPHA02653688136350
HP:0001028HP:0001028Hemangioma1FOXH1 CL E G H8928280200ORPHA0333814603621
HP:0001028HP:0001028Hemangioma1GAS1 CL E G H2619280200ORPHA064165139185
HP:0001028HP:0001028Hemangioma1GLI2 CL E G H2736280200ORPHA0884318165230
HP:0001028HP:0001028Hemangioma1LEMD3 CL E G H235921306Choreoacanthocytosis amyotrophicORPHA03428887607844
HP:0001028HP:0001028Hemangioma1NODAL CL E G H4838280200ORPHA0257865601265
HP:0001028HP:0001028Hemangioma1PTCH1 CL E G H5727280200ORPHA05299585601309
HP:0001028HP:0001028Hemangioma1SHH CL E G H6469280200ORPHA022110848600725
HP:0001028HP:0001028Hemangioma1SIX3 CL E G H6496280200ORPHA09110889603714
HP:0001028HP:0001028Hemangioma1SUFU CL E G H51684280200ORPHA04716466607035
HP:0001028HP:0001028Hemangioma1TDGF1 CL E G H6997280200ORPHA0611701187395
HP:0001028HP:0001028Hemangioma1TGIF1 CL E G H7050280200ORPHA02811776602630
HP:0001028HP:0001028Hemangioma1ZIC2 CL E G H7546280200ORPHA012312873603073
HP:0001028HP:0001028Hemangioma2ANTXR1 CL E G H841682067ORPHA01421014606410
HP:0001028HP:0001028Hemangioma2CDON CL E G H50937280200ORPHA01317104608707
HP:0001028HP:0001028Hemangioma2DISP1 CL E G H84976280200ORPHA01119711607502
HP:0001028HP:0001028Hemangioma2DLL1 CL E G H28514280200ORPHA0192908606582
HP:0001028HP:0001028Hemangioma2FGF8 CL E G H2253280200ORPHA0413686600483
HP:0001028HP:0001028Hemangioma2FGFR1 CL E G H2260280200ORPHA02653688136350
HP:0001028HP:0001028Hemangioma2FOXH1 CL E G H8928280200ORPHA0333814603621
HP:0001028HP:0001028Hemangioma2GAS1 CL E G H2619280200ORPHA064165139185
HP:0001028HP:0001028Hemangioma2GLI2 CL E G H2736280200ORPHA0884318165230
HP:0001028HP:0001028Hemangioma2LEMD3 CL E G H235921306Choreoacanthocytosis amyotrophicORPHA03428887607844
HP:0001028HP:0001028Hemangioma2NODAL CL E G H4838280200ORPHA0257865601265
HP:0001028HP:0001028Hemangioma2PTCH1 CL E G H5727280200ORPHA05299585601309
HP:0001028HP:0001028Hemangioma2SHH CL E G H6469280200ORPHA022110848600725
HP:0001028HP:0001028Hemangioma2SIX3 CL E G H6496280200ORPHA09110889603714
HP:0001028HP:0001028Hemangioma2SUFU CL E G H51684280200ORPHA04716466607035
HP:0001028HP:0001028Hemangioma2TDGF1 CL E G H6997280200ORPHA0611701187395
HP:0001028HP:0001028Hemangioma2TGIF1 CL E G H7050280200ORPHA02811776602630
HP:0001028HP:0001028Hemangioma2ZIC2 CL E G H7546280200ORPHA012312873603073
HP:0001028HP:0001028Hemangioma3ANTXR1 CL E G H841682067ORPHA01421014606410
HP:0001028HP:0001028Hemangioma3CDON CL E G H50937280200ORPHA01317104608707
HP:0001028HP:0001028Hemangioma3DISP1 CL E G H84976280200ORPHA01119711607502
HP:0001028HP:0001028Hemangioma3DLL1 CL E G H28514280200ORPHA0192908606582
HP:0001028HP:0001028Hemangioma3FGF8 CL E G H2253280200ORPHA0413686600483
HP:0001028HP:0001028Hemangioma3FGFR1 CL E G H2260280200ORPHA02653688136350
HP:0001028HP:0001028Hemangioma3FOXH1 CL E G H8928280200ORPHA0333814603621
HP:0001028HP:0001028Hemangioma3GAS1 CL E G H2619280200ORPHA064165139185
HP:0001028HP:0001028Hemangioma3GLI2 CL E G H2736280200ORPHA0884318165230
HP:0001028HP:0001028Hemangioma3LEMD3 CL E G H235921306Choreoacanthocytosis amyotrophicORPHA03428887607844
HP:0001028HP:0001028Hemangioma3NODAL CL E G H4838280200ORPHA0257865601265
HP:0001028HP:0001028Hemangioma3PTCH1 CL E G H5727280200ORPHA05299585601309
HP:0001028HP:0001028Hemangioma3SHH CL E G H6469280200ORPHA022110848600725
HP:0001028HP:0001028Hemangioma3SIX3 CL E G H6496280200ORPHA09110889603714
HP:0001028HP:0001028Hemangioma3SUFU CL E G H51684280200ORPHA04716466607035
HP:0001028HP:0001028Hemangioma3TDGF1 CL E G H6997280200ORPHA0611701187395
HP:0001028HP:0001028Hemangioma3TGIF1 CL E G H7050280200ORPHA02811776602630
HP:0001028HP:0001028Hemangioma3ZIC2 CL E G H7546280200ORPHA012312873603073


Genes (106) :ACVRL1 AGGF1 AKT1 ANTXR1 ARID1B ARL6IP6 ASXL1 BIN1 BRAF CCDC22 CCM2 CD96 CDON CPLX1 CREBBP CTBP1 CTSA CYP26C1 DHCR7 DIS3L2 DISP1 DLL1 DNM2 DPM1 DVL1 DVL3 EIF2AK4 ENG EP300 ESCO2 FGF8 FGFR1 FGFR2 FGFRL1 FH FLT4 FOXH1 FZD2 GAS1 GDF2 GLI2 GLI3 GNAQ GNPTAB GPC6 HOXD13 HRAS IDH1 IDH2 KDR KIF1B KLLN KRAS KRIT1 LEMD3 LETM1 MAP2K1 MAP2K2 MAX MDH2 MGAT2 MTM1 MTMR14 MYF6 NELFA NODAL NOTCH1 NRAS NSD2 OFD1 PDCD10 PIK3CA PTCH1 PTEN PTH1R PUF60 RASA1 RECQL4 RET RYR1 SDHA SDHAF2 SDHB SDHC SDHD SEC23A SEC23B SETBP1 SHH SIX3 SLC26A2 SMAD4 SRD5A3 SUFU TBC1D24 TBX2 TDGF1 TEK TFAP2A TGIF1 TMEM127 VHL WASHC5 WHCR WNT5A ZIC2

Diseases (76) :90308 176920 2067 135900 280200 194190 256540 398189 608799 153100 258315 163200 171300 1306 280 2969 616858 1297 263400 774 201 744 1556 605039 169189 115150 1340 7 221061 180849 2849 3107 2396 29072 602089 3205 185300 576 252500 887 2612 163634 596 616028 109 508488 608354 50814 607812 798 269150 222600 612713 79500 618223 1059 892 193300 818 270400 234810 1555 296 300209 60040 137608 56304 628 1308 3103 269000 268300 672 146510 212066 218600
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is June 2019 release.